2004 Annual Meeting | Crossfire II

Date Sunday 04/25/04

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Barney J. Stern, MD, FAAN

Topic(s) General Neurology/Neurology of Systemic Disease

Learning Objectives Upon completion:
Participants should be able to appreciate the fine points of patient diagnosis and management as highlighted by the case discussions.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
02:15 PM - 03:25 PM		Movement Disorders Anthony E. Lang, MD, FAAN, Stephen G. Reich, MD, FAAN
03:25 PM - 03:40 PM		Break
03:40 PM - 04:50 PM		Neuromuscular Diseases Mark B. Bromberg, MD, PhD, FAAN, Richard J. Barohn, MD, FAAN
04:50 PM - 06:00 PM		Epilespy Martha Morrell, MD, FAAN, Robert S. Fisher, MD, PhD, FAAN

Faculty Disclosures
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Mark B. Bromberg, MD, PhD, FAAN	Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Martha Morrell, MD, FAAN	Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Robert S. Fisher, MD, PhD, FAAN	Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epi-Minder Study, Australia (Mark Cook, PI). Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for START study (Hal Blumenfeld, PI). Dr. Fisher has stock in Avails Medical stock options (drug level testing). Dr. Fisher has stock in Eysz stock options (eye-movement seizure detection). Dr. Fisher has stock in Irody stock options (health records databases). Dr. Fisher has stock in Smart-Monitor stock options (shake-detector watch). Dr. Fisher has stock in Zeto stock options, dry, wireless EEG. The institution of Dr. Fisher has received research support from NaviFUS (focused ultrasound).
Barney J. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��